Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
TIGERMED Slumps 7% Post-Results; UBS: One-off Items Weigh on 1Q Earnings
Recommend 2 Positive 1 Negative 0 |
||||
|
||||
|
TIGERMED (03347.HK) opened 4.55% lower this morning (29th) and once bottomed at HKD39.78. It last traded at HKD40.76, down 7.36%, with a volume of 2.8713 million shares, involving HKD116 million. According to a report from UBS, TIGERMED's 1Q26 revenue rose by 15.2% YoY to RMB1.8 billion, broadly in line with the broker's and the market's expectations. However, net profit for the period plunged by 70.4% YoY to RMB49.04 million, as a RMB195 million fair value gain recorded by the company's consolidated investment funds led to an increase in profit attributable to non-controlling interests, which dragged down profit attributable to shareholders. Excluding one-off items, TIGERMED's net profit attributable to shareholders should have grown by 17.7% YoY to RMB120 million. UBS reiterated an Outperform rating on TIGERMED, with a target price of HKD56.1. Auto-translated by AI AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
